Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Autor principal: | Moreino, Shannon Sherwin |
---|---|
Outros Autores: | Kabir, Eva Rahman |
Formato: | Project report |
Idioma: | English |
Publicado em: |
BRAC University
2018
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/9331 |
Registos relacionados
-
Biologics and Biosimilars as Treatment Options for Psoriasis
Por: Moya, Amena Khatun
Publicado em: (2023) -
Biosimilar in lymphoma treatment
Por: Tanisha, Mehrin Haque
Publicado em: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
Por: Tabassum, Turana
Publicado em: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
Por: Tania, Umme
Publicado em: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Por: Tania, Umme
Publicado em: (2023)